BACITRACIN ZINC Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Bacitracin Zinc, and what generic alternatives are available?
Bacitracin Zinc is a drug marketed by Akorn, Bausch And Lomb, Padagis Us, Pharmafair, and Naska. and is included in six NDAs.
The generic ingredient in BACITRACIN ZINC is bacitracin zinc; neomycin sulfate; polymyxin b sulfate. There are twenty-seven drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the bacitracin zinc; neomycin sulfate; polymyxin b sulfate profile page.
Summary for BACITRACIN ZINC
US Patents: | 0 |
Applicants: | 5 |
NDAs: | 6 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for BACITRACIN ZINC |
DailyMed Link: | BACITRACIN ZINC at DailyMed |
Recent Clinical Trials for BACITRACIN ZINC
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Ohio State University | N/A |
Cairo University | Early Phase 1 |
University of Turin, Italy | N/A |